IC
RVMD icon

Ikarian Capital’s Revolution Medicines RVMD Stock Holding History

Ikarian Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-95,000
Closed -$7.57M – 205
2025
Q4 		$7.57M Hold
95,000
– – 0.59% 49
2025
Q3 		$4.44M Buy
+95,000
New +$3.72M 0.45% 59
2021
Q2 		– Sell
-150,000
Closed -$6.88M – 269
2021
Q1 		$6.88M Buy
+150,000
New +$6.73M 0.23% 97

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ikarian Capital's RVMD Position: Q1 2026 in Review

Ikarian Capital increased its Revolution Medicines (RVMD) stake by 18% in Q1 2026, buying an estimated $2.52M and bringing the position to 163,142 shares worth $15.9M. The position accounts for 1.29% of the portfolio, ranked #19.

Ikarian Capital first reported a position in RVMD in Q4 2025 and has held it in 2 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Ikarian Capital held 163,142 shares of Revolution Medicines worth $15.9M as of Q1 2026.
  • Ikarian Capital bought 25,000 Revolution Medicines shares in Q1 2026, an estimated $2.52M.
  • Revolution Medicines made up 1.29% of Ikarian Capital's portfolio in Q1 2026, its #19 holding.
  • Ikarian Capital first reported a position in Revolution Medicines in Q4 2025 and has held it in 2 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.